Why the study?
Cardiometabolic comorbidities like obesity, diabetes, and hypertension are prevalent in HF, but the association between their severity and hospitalization needed evaluation.
Does greater cardiometabolic comorbidity burden increase the risk of all-cause and HF hospitalization in patients with heart failure?
Does greater cardiometabolic comorbidity burden increase the risk of all-cause and HF hospitalization in patients with heart failure?
Greater cardiometabolic comorbidity burden is associated with a significantly increased risk of all-cause and HF hospitalization in patients with heart failure, regardless of ejection fraction.
Answers are grounded in this paper and cite their sources.
May support comorbidity optimization in HF; extends observational data linking multimorbidity burden to hospitalization risk.
BACKGROUND: Cardiometabolic comorbidities such as obesity, diabetes, and hypertension are highly prevalent in heart failure (HF). We aimed to examine the association between severity of cardiometabolic comorbidities and hospitalization in patients with HF. METHODS: . Cox regression models were used to assess the association between cardiometabolic comorbidity burden and time to all-cause and HF hospitalization at 1 year, adjusting for age, sex, race or ethnicity, and insurance status, smoking, prior hospitalization, and Elixhauser comorbidity index. Stratified analyses were conducted for HF with preserved and reduced ejection fraction. RESULTS: 13.7, 46% women, 69% White) experienced 4284 (16%) hospitalizations over a 1-year period. Compared with individuals with absent comorbidities, those with 1 or 2 to 3 severely uncontrolled comorbidities had a significantly higher risk of all-cause hospitalization (hazard ratio [HR], 1.23 [95% CI, 1.09-1.39] and HR, 1.57 [95% CI, 1.35-1.83], respectively). We found similar associations for HF hospitalization. These associations were similar among individuals with HF with preserved ejection fraction compared with HF with reduced ejection fraction. CONCLUSIONS: Greater cardiometabolic comorbidity burden was associated with increased risk of all-cause hospitalization in HF. This reinforces the role for targeting severely uncontrolled cardiometabolic comorbidities to reduce morbidity in HF.
No takes yet. Share an insight, caveat, or question.
Hamo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: